CRISPR Therapeutics Accounts Receivable (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

55.65 -0.76 (-1.35%) USD | NASDAQ | Apr 24, 16:00

55.93 +0.28 (+0.50%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	200.00M
September 30, 2023
June 30, 2023	70.00M
March 31, 2023
December 31, 2022	0.00
September 30, 2022	0.049M
June 30, 2022	0.066M
March 31, 2022	0.143M
December 31, 2021	0.305M
September 30, 2021	0.152M
June 30, 2021	0.15M
March 31, 2021	0.15M
December 31, 2020	0.144M
September 30, 2020	0.11M
June 30, 2020	0.033M
March 31, 2020	25.12M

Date	Value
December 31, 2019	0.099M
September 30, 2019	0.039M
June 30, 2019	0.321M
March 31, 2019	0.331M
December 31, 2018	0.088M
September 30, 2018	0.552M
June 30, 2018	0.944M
March 31, 2018	1.26M
December 31, 2017	2.626M
September 30, 2017	3.211M
June 30, 2017	6.814M
March 31, 2017	5.672M
December 31, 2016	3.157M
September 30, 2016	2.092M
June 30, 2016	1.354M
December 31, 2015	0.339M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

Minimum

Dec 2022

200.00M

Maximum

Dec 2023

17.46M

Average

0.144M

Median

Dec 2020

Accounts Receivable (Quarterly) Benchmarks